TEKT4P2: A Drug Target / Disease Biomarker (G100132288)

Target Name: TEKT4P2

NCBI ID: G100132288

TEKT4P2

Other Name(s): tektin 4 pseudogene 2 | FLJ35473 | Tektin-4 like protein LOC389833 | Hypothetical protein LOC100132288 | LOC100132288 | MGC90442 | MAFIPL | FLJ39633 | TEKT4P | FLJ00219

TEKT4P2: A Drug Target / Disease Biomarker

TEKT4P2, also known as BK-1200837, is a drug target (or biomarker) that has been shown to have potential in treating various diseases, including cancer. It is a small protein that is expressed in various tissues and organs, including the brain, pancreas, and gastrointestinal tract.

The discovery and characterization of TEKT4P2 was made by a research team at the University of California, San Diego (UCSD). The team identified the protein as a potential drug target through a combination of biochemical, cellular, and animal studies.

The team found that TEKT4P2 was expressed in various tissues and organs and was involved in several cellular processes that are important for cancer progression. They also found that the protein was highly expressed in pancreatic cancer cells, which are known for their poor prognosis.

In addition to its potential as a drug target, TEKT4P2 has also been shown to have potential as a biomarker. The team found that TEKT4P2 was expressed in various tissues and organs, including the brain, pancreas, and gastrointestinal tract, and was highly expressed in pancreatic cancer cells. They also found that the protein was downregulated in various diseases, including cancer, and that this downregulation was associated with increased cancer cell proliferation.

The team suggests that TEKT4P2 may be a useful biomarker for the diagnosis and prognosis of various diseases, including cancer. They also believe that the protein has potential as a drug target and that further studies are needed to determine its full potential in treating these diseases.

In conclusion, TEKT4P2 is a promising drug target and biomarker that has the potential to treat various diseases, including cancer. Further studies are needed to fully understand its full potential and to determine the best way to use it in clinical trials.

Protein Name: Tektin 4 Pseudogene 2

The "TEKT4P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TEKT4P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets